Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00767546 |
Date of registration:
|
05/10/2008 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
|
Scientific title:
|
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients |
Date of first enrolment:
|
May 2009 |
Target sample size:
|
40 |
Recruitment status: |
Not yet recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT00767546 |
Study type:
|
Interventional |
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
Phase 1
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Parkinson disease patients that have seborrhic dermatits
Exclusion Criteria:
- Dementia
- Renal or liver failure
- Pregnancy or breast feeding
- History of allergy to botolinum toxin
- Motor neuron disease or any other disease that insult the neuromuscular junction
- Treatment with Aminoglycoside antibiotic.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Parkinsonism
|
Seborrheic Dermatitis
|
Parkinson Disease
|
Intervention(s)
|
Drug: Botulinum toxin
|
Primary Outcome(s)
|
Clinical assesment of the rash Photometric test of sebum exertion
[Time Frame: 4 month]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|